Capital International Investors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,310,109
| Closed | -$26.2M | – | 436 |
|
|
2023
Q1 | $26.2M | Hold |
5,310,109
| – | – | 0.01% | 373 |
|
|
2022
Q4 | $33.4M | Hold |
5,310,109
| – | – | 0.01% | 350 |
|
|
2022
Q3 | $57.3M | Buy |
5,310,109
+982,767
| +23% | +$10.6M | 0.02% | 328 |
|
|
2022
Q2 | $49.3M | Buy |
4,327,342
+3,740,264
| +637% | +$42.6M | 0.01% | 346 |
|
|
2022
Q1 | $5.35M | Sell |
587,078
-992,031
| -63% | -$9.04M | ﹤0.01% | 432 |
|
|
2021
Q4 | $23.6M | Sell |
1,579,109
-1,955,278
| -55% | -$29.2M | 0.01% | 397 |
|
|
2021
Q3 | $90.8M | Buy |
3,534,387
+9,273
| +0.3% | +$238K | 0.02% | 305 |
|
|
2021
Q2 | $91.9M | Sell |
3,525,114
-3,073,922
| -47% | -$80.2M | 0.02% | 306 |
|
|
2021
Q1 | $233M | Sell |
6,599,036
-529,183
| -7% | -$18.7M | 0.06% | 226 |
|
|
2020
Q4 | $180M | Sell |
7,128,219
-136,170
| -2% | -$3.44M | 0.05% | 248 |
|
|
2020
Q3 | $274M | Buy |
7,264,389
+49,476
| +0.7% | +$1.87M | 0.08% | 192 |
|
|
2020
Q2 | $309M | Buy |
7,214,913
+2,636,113
| +58% | +$113M | 0.1% | 169 |
|
|
2020
Q1 | $89M | Buy |
4,578,800
+690,779
| +18% | +$13.4M | 0.04% | 221 |
|
|
2019
Q4 | $101M | Sell |
3,888,021
-52,538
| -1% | -$1.36M | 0.03% | 234 |
|
|
2019
Q3 | $107M | Buy |
3,940,559
+17
| +0% | +$463 | 0.04% | 221 |
|
|
2019
Q2 | $106M | Buy |
3,940,542
+1,908,988
| +94% | +$51.3M | 0.04% | 234 |
|
|
2019
Q1 | $58.7M | Hold |
2,031,554
| – | – | 0.03% | 259 |
|
|
2018
Q4 | $54.7M | Buy |
+2,031,554
| New | +$54.7M | 0.03% | 241 |
|